Dysregulation of apoptosis in cancer

Cancer Journal from Scientific American

Volumn 4, Issue SUPPL. 1, 1998, Pages

  Reed, John C ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL DEATH; HUMAN; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CYSTEINE ENDOPEPTIDASES; HOMEOSTASIS; HUMANS; MITOCHONDRIA; MODELS, BIOLOGICAL; NEOPLASMS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0031843732     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-1462.
2. Tsujimoto Y, Crossman J, Jaffe E et al. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985;228:1440-1443.
3. Tsujimoto Y, Croce CM. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Nad Acad Sci USA 1986;83:5214-4218.
4. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994;124:1-6.
5. Reed JC. Bcl-2: Prevention of apoptosis as a mechanism of drug resistance. Hematol Oncol Clin North Am 1995;9:451-474.
6. Miyashita T, Harigai M, Hanada M et al. Identification of a p53-dependent negative response element in the Bcl-2 gene. Cancer Res 1994;54:3131-3135.
7. Delia D, Aiello A, Formelli F et al. Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl) retinamide and effect of deregulated bcl-2. Blood 1995;85:359-367.
8. Reed JC. Cell death and the bcl-2 gene. Contemp Oncol 1994;4: 29-42.
9. Reed JC. Regulation of apoptosis by Bcl-2 family proteins and its role in cancer and chemoristance. Curr Opin Oncol 1995;7:541-546.
10. Krajewski S, Mai JK, Krajewska M et al. Upregulation of bax protein levels in neurons following cerebral ischemia. J Neurosci 1995;15:6364-6376.
11. Zhan Q, Fan S, Bae I et al. Induction of BAX by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene 1994;9:3743-3751.
12. Miyashita T, Krajewski S, Krajewska M et al. Tumor suppressor p53 is a regulator of BCL-2 and BAX in gene expression in vitro and in vivo. Oncogene 1994;9:1799-1805.
13. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of human BAX gene. Cell 1995;80:293-299.
14. Kitada S, Krajewski S, Miyashita T et al. γ-Radiation induces upregulation of Bax protein and apoptosis in radiosensitive cells in vivo. Oncogene 1996;12:187-192.
15. Krajewski S, Blomvqvist C, Franssili K et al. Reduced expression of pro-apoptotic gene Bax is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res 1995;55:4471-4478.
16. Krajewski S, Thor AD, Edgerton SM et al. Immunohistochemical analysis of Bax and Bcl-2 in p53-immunopositive breast cancers. Clin Cancer Res 1996;3:199-208.
17. Reed JC. Balancing cell life and death: Bax, apoptosis, and breast cancer. J Clin Invest 1996;97:2403-2404.
18. Krajewska M, Moss S, Krajewski S et al. Elevated expression of Bd-X and reduced Bak in primary colorectal adenocarcinomas. Cancer Res 1996;56:2422-2427.
19. Yin XM, Oltvai ZN, Korsmeyer SJ. BH1 and BH2 domains of bcl-2 are required for inhibition of apoptosis and heterodimerization with bax. Nature 1994;369:321-333.
20. Cheng EH-Y, Levine B, Boise LH et al. Bax-independent inhibition of apoptosis by Bcl-Xl. Nature 1996;379:554-556.
21. Zha H, Reed JC. Heterodimerization-independent functions of cell death regulatory proteins Bax and Bcl-2 in yeast and mammalian cells. J Biol Chem 1997;272:31482-31488.
22. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 1997;3:614-620.
23. Patel T, Gores GJ, Kaufmann SH. The role of proteases during apoptosis. FASEB J 1996;10:587-597.
24. Martin SJ, Green DR. Protease activation during apoptosis: death by a thousand cuts? Cell 1995;82:349-352.
25. Salvesen G, Dixit VM. Caspase: intracellular signaling by proteolysis. Cell 1997;91:443-446.
26. Alnemri ES, Livingston DJ, Nicholson DW et al. Human ICE/ CED-3 protease nomenclature. Cell 1996;87:171.
27. Orth K, O'Rourke K, Salvesen GS et al. Molecular ordering of apoptotic mammalian CED-3/ICE-like proteases. J Biol Chem 1996;271:20977-20980.
28. Fernandes-Alnemri T, Armstrong RC, Krebs J et al. Activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc Natl Acad Sci USA 1996;93:7464-7469.
29. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995;81:505-512.
30. Boldin MP, Varfolomeev EE, Pancer Z et al. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 1995;270:7795-7798.
31. Muzio M, Chinnaiyan AM, Kischkel FC et al. Flice, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (FAS/APO-1) death inducing signalling complex. Cell 1996;85: 817-827.
32. Boldin MP, Goncharov TM, Goltsev YV et al. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/ APO-I- and TNF receptor-induced cell death. Cell 1996;85:803-815.
33. Srinivasula S, Ahmad M, Fernandes-Alenri T et al. Molecular ordering of the fas-apoptic pathway: The fas/APO-1 protease Mch5 is a CrmA-inhibitable protease that activates multiple Ced-3/ICE-like cysteine proteases. Proc Natl Acad Sci USA 1996;93: 14486-14491.
34. Muzio M, Salvesen GS, Sizit VM. FLICE-induced apoptosis in a cell-free system. J Biol Chem 1997;272:2952-2956.
35. Petit PX, Susin S-A, Zamzami N et al. Mitochondria and programmed cell death: back to the future. FEBS Lett 1996;396:7-13.
36. Liu X, Kim CN, Yang J et al. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome C. Cell 1996;86:147-157.
37. Zou H, Henzel WJ, Liu X et al. A human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 1997;90:405-413.
38. Yang J, Liu X Bhalla K et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 1997;275:1129-1132.
39. Kluck RM, Bossy-Wetzel E, Green DR et al. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997;275:1132-1136.
40. Muchmore SW, Sattler M, Liang H. X-ray and NMR structure of human Bel-XL, an inhibitor of programmed cell death. Nature 1996;381:335-341.
41. Aritomi M, Kunishima N, Inohara N et al. Crystal structure of rat Bcl-XL: implications for the function of the Bcl-2 protein family. J Biol Chem 1997;272:27886-27892.
42. Donovan JJ, Simon MI, Montal M: Requirements for the translocation of diphtheria toxin fragment A across lipid membranes. J Biol Chem 1985;260:8817-8823.
43. Antonsson B, Conti F, Ciavatta A et al. Inhibition of Bax channel-forming activity by Bcl-2. Science 1997;277:370-372.
44. Spector MS, Desnoyers S, Heoppner DJ et al. Interaction between the C. elegans cell-death regulators CED-9 and CED-4. Nature 1997;385:653-656.
45. Wu D, Wallen HD, Nunez G. Interaction and regulation of subcellular localization of CED-4 by CED-9. Science 1997;275: 1126-1129.
46. Chinnaiyan AM, O'Rourke K, Lane BR et al. Interaction of CED-4 with CED-3 and CED-9: a molecular framework for cell death. Science 1997;275:1122-1126.
47. Seshagiri S, Miller L. Caenorhabditis elegans CED-4 stimulates CED-3 processing and CED-3-induced apoptosis. Curr Biol 1997;7:455-460.
48. Susin S, Zamzami N, Castedo M et al. The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO-1/CD95- and ceramide-induced apoptosis. J Exp Med 1997;186:25-37.
49. Marzo I, Brenner C, Zamzami N et al. The permeability transition pore complex: a target for apoptosis regulation by caspases and Bcl-2-related proteins. Nat Med 1997 (in press).
50. Peter ME, Kischkel FC, Scheuerpflug CG et al. Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/caspase 8) to die CD95 death-inducing signalling complex. Eur J Immunol 1997; 27:1207-1212.
51. Friesen C, Herr I, Krammer PH et al. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug induced apoptosis in leukemia cells. Nat Med 1996;2:574-577.
52. Houghton JA, Haarwood FG, Tillman DM. Thymineless death in colon carcinoma cells is mediated via fas signaling. Proc Natl Acad Sci USA 1997;94:8144-8149.
53. Reed JC. Double identity for proteins of the Bcl-2 family. Nature 1997;387:773-776.
54. L. Cell 1996;87:619-628.
55. Wang HG, Rapp UR, Reed JC. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 1996;87:629-638.
56. Del Peso L, González-Garcia M, Page C et al. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 1997;278:687-689.
57. Takayama S, Bimston DN, Matsuzawa S et al. BAG-1 modulates the chaperone activity of Hsp70/Hsc70. EMBOJ 1997;16:4887-4896.
58. Takayama S, Sato T, Krajewski S et al. Cloning and functional analysis of BAG-1: a novel Bcl-2 binding protein with anti-cell death activity. Cell 1995;80:279-284.
59. Sattler M, Liang H, Nettesheim D et al. Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Science 1997;275:983-986.
60. L forms an ion channel in synthetic lipid membranes. Nature 1997;385:353-357.
61. Schendel SL, Xie Z, Montal MO et al. Channel formation by anti-apoptotic protein Bcl-2. Proc Natl Acad Sci USA 1997;94:5113-5118.
62. Deveraux Q, Takahashi R, Salvesen GS et al. X-linked IAP is a direct inhibitor of cell death proteases. Nature 1997;388:300-303.
63. Roy N, Deveraux QL, Takahashi R et al. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J 1997; 16:6914-6925.
64. Ambrosini G, Adida C, Altieri D. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997;3: 917-921.
65. Imler M, Thome M, Hahne M et al. Inhibition of death receptor signals by cellular FLIP. Nature 1997;388:190-195.
66. Srinivasula SM, Ahmad M, Ottilie S et al. FLAME-1, a novel FADD-like anti-apoptotic molecule that regulates Fas-TNFR1-induced apoptosis. J Biol Chem 1997;272:18542-18545.
67. Gougeon M-L, Lecoeur H, Dulioust A et al. Programmed cell death in peripheral lymphocytes from HIV-infected persons. J Immunol 1996;156:3509-3520.
68. Sato T, Irie S, Kitada S et al. FAP-1: A protein tyrosine phosphatase that associates with Fas. Science 1995;268:411-415.
69. Yang X, Khosravi-Far R, Chang HY et al. Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 1997;89:1067-1076.
70. Yanagisawa J, Takahashi M, Kanki H et al. The molecular interaction of Fas and FAP-1: a tripeptide blocker of human Fas interaction with FAP-1 promotes Fas-induced apoptosis. J Biol Chem 1997;272:8539-8545.